3200 Lakeside Dr.
Santa Clara
CA
95054
USA
(408) 845-3000
Related Content
November 4, 2014 — The U.S. Food and Drug Administration (FDA) has cleared the Abbott family of Xience everolimus ...
November 04, 2014
Feature | Dave Fornell
There are several hemostasis devices that can help cath labs improve efficiency by reducing nursing time in the recovery ...
November 03, 2014
Oct. 29, 2014 – Abbott has entered into an agreement to purchase Topera Inc., a private, venture-backed medical device ...
October 29, 2014
October 27, 2014 – Annie Henderson, 69, suffers from multiple chronic ailments, including kidney failure and mitral ...
October 27, 2014
October 8, 2014 — Abbott announced the start of the ABSORB IV clinical trial, which will test whether the Absorb ...
October 08, 2014
DAIC Editor, Dave Fornell, interviews Jim Hermiller, M.D., FACC, director of interventional cardiology, St. Vincent ...
September 24, 2014
ABSORB II Study Shows Abbott's Dissolving Heart Device Comparable to the World's Leading Heart Stent
September 24, 2014 — Abbott announced positive one-year clinical results from ABSORB II, the world's first prospective ...
September 24, 2014
Feature | Stents Bioresorbable| Dave Fornell
(UPDATE: read the Sept. 8, 2017 article "Abbott Will End Sales of Absorb Bioresorbable Stent") A key prediction for ...
September 03, 2014August 12, 2014 — The Centers for Medicare and Medicaid (CMS) took action to improve access to Abbott’s MitraClip system ...
August 12, 2014
July 29, 2014 — Mary York knew the walk from the living room to the bedroom should not have been difficult for her ...
July 29, 2014